Papillary Thyroid Carcinoma Metastatic to the Pituitary Gland
Authors:
- Inaam A. NakchbandiINInaam A. Nakchbandi
- Andrew F. StewartASAndrew F. Stewart
- Silvio E. InzucchiSISilvio E. Inzucchi
- 1 October 1999
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 9 (10) , 1023-1027
Abstract
Many malignancies may present with metastases to the pituitary gland. The association of thyroid carcinoma with pituitary metastases is, however, very rare. This report describes two patients in whom metastases from a papillary thyroid carcinoma to the pituitary gland resulted in panhypopituitarism with blunted endogenous thyrotropin (TSH) production following withdrawal of levothyroxine. Both required the use of recombinant human TSH prior to radioiodine therapy. Symptoms of hypopituitarism may be difficult to distinguish clinically from those of hypothyroidism in the setting of levothyroxine withdrawal. Clinicians should be aware of the clinical and biochemical manifestations of this rare association.Keywords
This publication has 13 references indexed in Scilit:
- Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid CarcinomaNew England Journal of Medicine, 1997
- Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine 131I and Recombinant Human Thyroid Stimulating HormoneThe Journal of Clinical Endocrinology & Metabolism, 1997
- Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarismThe Journal of Clinical Endocrinology & Metabolism, 1996
- Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study)The Journal of Clinical Endocrinology & Metabolism, 1994
- Distant Metastases in Differentiated Thyroid Cancer: Long-term Results of Radioiodine Treatment and Statistical Analysis of Prognostic Factors in 214 PatientsTumori Journal, 1991
- Metastatic Tumors of the Sella Turcica Masquerading as Primary Pituitary Tumors*The Journal of Clinical Endocrinology & Metabolism, 1987
- Presentation and management of parasellar and suprasellar metastatic mass lesions.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Pituitary metastasisNeurology, 1981
- Functioning Metastasis of Thyroid Carcinoma in the Sella TurcicaThe Journal of Clinical Endocrinology & Metabolism, 1965
- ADENOCARCINOMA OF THE THYROID, WITH METASTASIS TO THE CERVICAL GLANDS AND PITUITARYThe American Journal of the Medical Sciences, 1912